PPA
IMUX icon

Parametric Portfolio Associates’s Immunic IMUX Stock Holding History

Parametric Portfolio Associates’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-28
Closed -$49K – 3794
2016
Q4 		$49K Buy
28
+1
+4% +$2.19K ﹤0.01% 3741
2016
Q3 		$66K Sell
27
-5
-16% -$12.3K ﹤0.01% 3718
2016
Q2 		$78K Sell
32
-6
-16% -$19.7K ﹤0.01% 3751
2016
Q1 		$139K Buy
38
+4
+12% +$13.9K ﹤0.01% 3813
2015
Q4 		$159K Buy
34
+4
+13% +$13.1K ﹤0.01% 3784
2015
Q3 		$49K Buy
+30
New +$150K ﹤0.01% 3241

Other funds holding IMUX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's IMUX Position: Q1 2017 in Review

Parametric Portfolio Associates sold out of Immunic (IMUX) in Q1 2017, closing a stake of 28 shares — an estimated $49K sold.

Parametric Portfolio Associates first reported a position in IMUX in Q3 2015 and held it in 6 quarters. The position peaked at $159K in Q4 2015. 53 funds tracked by Wall St. Rank hold IMUX as of Q1 2017.

  • Parametric Portfolio Associates reported no remaining Immunic position as of Q1 2017 after selling out during the quarter.
  • Parametric Portfolio Associates sold 28 Immunic shares in Q1 2017, an estimated $49K.
  • Parametric Portfolio Associates first reported a position in Immunic in Q3 2015 and held it in 6 quarters.
  • Parametric Portfolio Associates's Immunic position peaked at $159K in Q4 2015.
  • 53 funds tracked by Wall St. Rank held Immunic as of Q1 2017.

Based on Parametric Portfolio Associates's 13F filing for Q1 2017, filed 8 May 2017.